C-reactive protein as a biomarker of emergent osteoarthritis.
暂无分享,去创建一个
Laurie Lachance | MaryFran Sowers | M. Hochberg | M. Jannausch | D. Jamadar | Marc Hochberg | David Jamadar | M. Sowers | Mary Jannausch | Evan Stein | L. Lachance | E. Stein
[1] E. Vignon,et al. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. , 1998, Revue du rhumatisme.
[2] J. Dingle,et al. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation. , 1987, International journal of tissue reactions.
[3] E. Martı́n-Mola,et al. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. , 1997, The Journal of rheumatology.
[4] T. Kikuchi,et al. Production of cytokines by chondrocytes and its role in proteoglycan degradation. , 1991, The Journal of rheumatology. Supplement.
[5] M. Sowers,et al. Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women. , 2000, Osteoarthritis and cartilage.
[6] S. Krane,et al. Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. , 1979, The Journal of clinical investigation.
[7] S. Ricard-Blum,et al. Type IX collagen is a potent inducer of PGE2 and interleukin 1 production by human monocyte macrophages , 1986, FEBS letters.
[8] E. Thonar,et al. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. , 1998, Osteoarthritis and cartilage.
[9] K. Brandt,et al. Synovial inflammation in patients with early osteoarthritis of the knee. , 1990, The Journal of rheumatology.
[10] R. Cooper,et al. Relationships between local inflammation, interleukin‐6 concentration and the acute phase protein response in arthritis patients , 1991, European journal of clinical investigation.
[11] P. Dieppe,et al. Elevated serum C-reactive protein levels in osteoarthritis. , 1997, British journal of rheumatology.
[12] S. Goodman,et al. Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids. , 1984, Clinical and experimental immunology.
[13] S. Crawford,et al. Design, survey sampling and recruitment methods of SWAN: A multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition , 2000 .
[14] J. Sipe. Acute-phase proteins in osteoarthritis. , 1995, Seminars in arthritis and rheumatism.
[15] M. Suthanthiran,et al. Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients , 1998 .
[16] G. Ramadori,et al. Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐α , 1988 .
[17] S. Krane,et al. Stimulation of procollagenase synthesis in human rheumatoid synovial fibroblasts by mononuclear cell factor/interleukin 1 , 1985, FEBS letters.
[18] P. Sehgal,et al. Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation , 1986, Cell.
[19] J. Pelletier,et al. Neutral proteases in human osteoarthritic synovium. , 1986, Arthritis and rheumatism.
[20] H. Schumacher,et al. Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis. , 1996, The Journal of rheumatology.
[21] P. Dieppe,et al. Synovial fluid concentration of five different cytokines in rheumatic diseases. , 1990, Annals of the rheumatic diseases.
[22] J. Pelletier,et al. Are cytokines involved in osteoarthritic pathophysiology? , 1991, Seminars in arthritis and rheumatism.
[23] J. Pujol,et al. The role of cytokines in the development of osteoarthritis. , 1990, Scandinavian journal of rheumatology. Supplement.
[24] M. Pepys,et al. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.
[25] K. Maurer. Basic data on arthritis knee, hip, and sacroiliac joints in adults ages 25-74 years. , 1979, Vital and health statistics. Series 11, Data from the National Health Survey.
[26] J. Vilček,et al. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. , 1991, The Journal of biological chemistry.
[27] G. Firestein,et al. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. , 1990, The Journal of clinical investigation.
[28] J. Kelsey,et al. Menopause : biology and pathobiology , 2000 .
[29] W. Fiers,et al. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. , 1993, Immunobiology.
[30] In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility , 1998, Rheumatology International.
[31] I. Kushner,et al. Monokines regulate glycosylation of acute-phase proteins , 1987, The Journal of experimental medicine.
[32] P. Hart,et al. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. , 1988, The Journal of rheumatology.
[33] A. Mackiewicz,et al. Affinity electrophoresis for studies of mechanisms regulating glycosylation of plasma proteins , 1989, Electrophoresis.
[34] P. Guerne,et al. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.
[35] James D. Kang,et al. Herniated Cervical Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin‐6, and Prostaglandin E2 , 1995, Spine.
[36] C. Mold,et al. C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.
[37] C. Dinarello,et al. Isolation of an interleukin-1-like factor from human joint effusions. , 1983, Arthritis and rheumatism.
[38] L. Old,et al. Tumor necrosis factor (TNF). , 1985, Science.
[39] J. Schölmerich,et al. Interleukins and their antagonists but not TNF and its receptors are released in post‐ERP pancreatitis , 1998, European journal of gastroenterology & hepatology.
[40] T. Spector,et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.
[41] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.
[42] M. Hochberg,et al. Why does osteoarthritis of the knee hurt--sometimes? , 1997, British journal of rheumatology.
[43] F. Wolfe. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. , 1997, The Journal of rheumatology.
[44] J. Lawrence,et al. Osteo-Arthrosis: Prevalence in the Population and Relationship between Symptoms and X-ray Changes , 1966, Annals of the rheumatic diseases.
[45] L. Kazis,et al. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. , 1987, Arthritis and rheumatism.
[46] D. Goldenberg,et al. Inflammatory synovitis in degenerative joint disease. , 1982, The Journal of rheumatology.
[47] J. S. Lawrence,et al. The Epidemiology of Chronic Rheumatism , 1964 .